An ISO 9001:2008 & GMP certified company  | info@arlakbiotech.com  |  +91-9803023099, 7696263636  |  1800-121-6263 (Toll Free) 

NOIRMOX-D E/E DROP


COMPOSITION: MOXIFLOXACIN 0.5% & DEXAMETHASONE 0.1%

PACKING: 5 ML

Categories: , .
Description

MOXIFLOXACIN

Treating eye infections caused by certain bacteria. Moxifloxacin drops are a fluoroquinolone. It works by killing sensitive bacteria by stopping the production of essential proteins needed by the bacteria to survive.

MECHANISM OF ACTION

Moxifloxacin is a member of the fluoroquinolone class of anti-infective drugs.

PHARMACOKINETICS

Moxifloxacin steady-state plasma pharmacokinetics were evaluated in healthy adult male and female subjects who were administered multiple bilateral,topical ocular doses of MOXEZA™ solution two times daily for four days with a final dose on day 5. The average steady-state AUC0-12 was 8.17 ± 5.31 ng•h/mL. Moxifloxacin Cmax following twice-daily bilateral ophthalmic administration of moxifloxacin AF 0.5% for 5 days is approximately 0.02% of that achieved with the oral formulation of moxifloxacin hydrochloride (Cmax following oral dosing of 400 mg AVELOX*, 4.5 ± 0.5 mcg/mL).

DEXAMETHASONE

Dexamethasone is a steroid used to treat inflammation.

Dexamethasone intravitreal is an implant injected into the eye to treat swelling that may occur when there is a blockage of certain blood vessels in your eyes.

Dexamethasone ophthalmic is used to treat eye inflammation caused by infections, injury, surgery, or other conditions.

Contact Us
close slider